Molecular and Cellular Biology, July 2005, p. 6065-6076, Vol. 25, No. 14
0270-7306/05/$08.00+0 doi:10.1128/MCB.25.14.6065-6076.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Dysregulation of the Peroxisome Proliferator-Activated Receptor Target Genes by XPD Mutations
Emmanuel Compe,1
Pascal Drané,1
Camille Laurent,1
Karin Diderich,2
Cathy Braun,1
Jan H. J. Hoeijmakers,2 and
Jean-Marc Egly1*
Institut de Génétique et de Biologie Moléculaire et Cellulaire, BP 10142, 67404 Illkirch Cedex, C. U. Strasbourg, France,1
MGC-Department of Cell Biology and Genetics, Centre for Biomedical Genetics, Erasmus Medical Center, 3000 DR Rotterdam, The Netherlands2
Received 9 February 2005/
Returned for modification 31 March 2005/
Accepted 27 April 2005
Mutations in the XPD subunit of TFIIH give rise to human genetic disorders initially defined as DNA repair syndromes. Nevertheless, xeroderma pigmentosum (XP) group D (XP-D) patients develop clinical features such as hypoplasia of the adipose tissue, implying a putative transcriptional defect. Knowing that peroxisome proliferator-activated receptors (PPARs) are implicated in lipid metabolism, we investigated the expression of PPAR target genes in the adipose tissues and the livers of XPD-deficient mice and found that (i) some genes are abnormally overexpressed in a ligand-independent manner which parallels an increase in the recruitment of RNA polymerase (pol) II but not PPARs on their promoter and (ii) upon treatment with PPAR ligands, other genes are much less induced compared to the wild type, which is due to a lower recruitment of both PPARs and RNA pol II. The defect in transactivation by PPARs is likely attributable to their weaker phosphorylation by the cdk7 kinase of TFIIH. Having identified the phosphorylated residues in PPAR isotypes, we demonstrate how their transactivation defect in XPD-deficient cells can be circumvented by overexpression of either a wild-type XPD or a constitutively phosphorylated PPAR S/E. This work emphasizes that underphosphorylation of PPARs affects their transactivation and consequently the expression of PPAR target genes, thus contributing in part to the XP-D phenotype.
* Corresponding author. Mailing address: IGBMC, BP 10142, 67404 Illkirch Cedex, France. Phone: 33 (0)3 88 65 34 47. Fax: 33 (0)3 88 65 32 01. E-mail: egly{at}titus.u-strasbg.fr.
Molecular and Cellular Biology, July 2005, p. 6065-6076, Vol. 25, No. 14
0022-538X/05/$08.00+0 doi:10.1128/MCB.25.14.6065-6076.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Sugasawa, K.
(2008). Xeroderma pigmentosum genes: functions inside and outside DNA repair. Carcinogenesis
29: 455-465
[Abstract]
[Full Text]
-
Lewis, A. E., Rusten, M., Hoivik, E. A., Vikse, E. L., Hansson, M. L., Wallberg, A. E., Bakke, M.
(2008). Phosphorylation of Steroidogenic Factor 1 Is Mediated by Cyclin-Dependent Kinase 7. Mol. Endocrinol.
22: 91-104
[Abstract]
[Full Text]
-
Quignodon, L., Grijota-Martinez, C., Compe, E., Guyot, R., Allioli, N., Laperriere, D., Walker, R., Meltzer, P., Mader, S., Samarut, J., Flamant, F.
(2007). A combined approach identifies a limited number of new thyroid hormone target genes in post-natal mouse cerebellum. J Mol Endocrinol
39: 17-28
[Abstract]
[Full Text]
-
Laposa, R. R., Huang, E. J., Cleaver, J. E.
(2007). Increased apoptosis, p53 up-regulation, and cerebellar neuronal degeneration in repair-deficient Cockayne syndrome mice. Proc. Natl. Acad. Sci. USA
104: 1389-1394
[Abstract]
[Full Text]
-
Relic, B., Benoit, V., Franchimont, N., Kaiser, M.-J., Hauzeur, J.-P., Gillet, P., Merville, M.-P., Bours, V., Malaise, M. G.
(2006). Peroxisome Proliferator-activated Receptor-{gamma}1 Is Dephosphorylated and Degraded during BAY 11-7085-induced Synovial Fibroblast Apoptosis. J. Biol. Chem.
281: 22597-22604
[Abstract]
[Full Text]
-
Iankova, I., Petersen, R. K., Annicotte, J.-S., Chavey, C., Hansen, J. B., Kratchmarova, I., Sarruf, D., Benkirane, M., Kristiansen, K., Fajas, L.
(2006). Peroxisome Proliferator-Activated Receptor {gamma} Recruits the Positive Transcription Elongation Factor b Complex to Activate Transcription and Promote Adipogenesis. Mol. Endocrinol.
20: 1494-1505
[Abstract]
[Full Text]
-
Fisher, R. P.
(2005). Secrets of a double agent: CDK7 in cell-cycle control and transcription. J. Cell Sci.
118: 5171-5180
[Abstract]
[Full Text]
Copyright © 2005 by the American Society for Microbiology. All rights reserved.